Rbg Share Discussion Threads

[buying] 12/10/2020 12:22

ST of the investors Chronicle maintains his one pound price target

[yellowstoneadvisory] 09/10/2020 14:41

Join a webinar with management next Thursday 15th at 4pm to hear update on trading

register here: hxxps://us02web.zoom.us/webinar/register/5716020720349/WN_x1vr6lu4RPyCAQPYgGxJ-w

[energeticbacker] 07/10/2020 09:34

Investor's Champion comments on RBGP's welcome boost on better news from its portfolio of companies.

The shares trade at only 8.5x reported earnings per share for 2019, suggesting significant recovery potential.

[sphere25] 06/10/2020 09:50

So that's why they were buying - suspect market action.

[sphere25] 05/10/2020 11:24

Interesting to see some large buying into the close on Friday afternoon after the recent sell off. Some decent buying coming in now too.

Any more big buys to follow?

[paleje] 18/9/2020 00:05

ST comments in his column yesterday the market has overreacted to the results. Value will out in H2.

[scooper72] 16/9/2020 19:48

Sorry but what happened today. Did I miss some news. My HL account hasn't got any news under the share info. ...always knew I should be trading this a bit - this is about the 3rd time it has dropped back. Might just have to open a little spread bet to complement the IsA holding.

[quepassa] 16/9/2020 18:42

One notes that the name Islero was given to a Spanish Miura fighting bull famed for killing the celebrated bullfighter Manolete in August 1947.


ALL IMO. DYOR.
QP

[bubloo] 16/9/2020 13:41

que passa .Nothing to worry. they have saved themselves paying the 6 million deferred payment to convex. second half results will be stonking. they did give a clue about this in the webcast. I am in with a small punt. most redeeming thing is that the gehc litigation is not directed at them which was worrying me.
50% upside in 6/12

[thirty fifty twenty] 14/9/2020 10:38

hello

any got any interesting conspiracy theories as to why RBGP changed the time of their results presentation from 4pm to 11am on Wednesday. I found it a bit surprising it was changed with such short notice, and that the change came at 10pm on a Sunday!!

mostly likely is a simple mess up (probably) by the meeting organiser you;d assume,
but if it is a genuine change because of a change - they it must be a pretty important meeting that the CEO needs to attend at 4.30 to cause themselves the embarrassment of changing the times at 2 days notice, and on a Sunday

thoughts welcome

All IMHO, DYOR + BoL
RBGP is in my top5 hldgs

[quepassa] 03/9/2020 11:07

Interesting report.

all imo. dyor.
qp

[jamesbone] 03/9/2020 10:35

hxxps://www.lawgazette.co.uk/law/city-firm-billed-millions-but-left-clients-interest-in-the-rear-view-mirror/5105432.article

[quepassa] 02/9/2020 15:40

???simile???

"Some people would class both as pests who scavenge from others, though most concede lawyers have their uses."

hope the FT lawyers don't do you for defamation and/or breach of copyright/reproduction.

all imo.dyor.
qp

[jonwig] 02/9/2020 15:16

Incidentally, there's a presentation coming up (16/09; 4:30pm). Anyone can join:

[buying] 17/7/2020 09:47

Although I think it's very optimistic to say the share price will double there is a growth story unfolding here. I've bought in and out over the years but think I will stay put for a while. There's a dividend while you wait

[quepassa] 17/7/2020 09:18

yes, but he is frequently wide of his mark.

all imo. dyor.
qp

[devilsprofessor] 17/7/2020 08:21

Good article in this weeks Investors Chronicle by Simon Thompson regarding how sorely undervalued this share is. In fact he is as bold as to say he expects to 'double money' within twelve months.DYO as always guys.

[scubadiverr] 16/7/2020 23:04

https://www.rosenblatt-law.co.uk/media/rosenblatt-acts-for-simon-cowell-in-sony-deal/

[quepassa] 14/7/2020 09:06

The latest Trading Update sounds very different to me.

The latest JULY trading update is well worth re-reading

Post 245 refers.


ALL IMO. DYOR.
QP

[standish11] 14/7/2020 07:23

In early June, I suggested buying shares in RBG (RBGP:65p), a professional services group that owns law firm, Rosenblatt, a nascent litigation funding arm, and specialist finance boutique Convex Capital (Alpha Report: ‘Back a winning legal team’, 2 June 2020).

A pre-close trading update released ahead of first half results on Wednesday, 16 September 2020 makes me even more convinced that there is potential to double your money over the next 12 months. Rosenblatt has enjoyed a good lockdown, winning a broad range of new instructions, including corporate transactions, employment advisory work and financial restructuring mandates. In fact, Rosenblatt’s first half revenue has soared 38 per cent to £11.2m.

It’s high margin work, too, generating a 40 per cent cash profit margin. That’s because Rosenblatt’s team of 46 fee-earning legal eagles specialise in litigious/contentious work that enables the firm to bill clients by the hour and control the level of fees it charges. Dispute resolution-related work accounts for two thirds of the business whereas listed rivals have greater exposure to more commoditised general legal services work which has lower pricing and where fixed fee structures are common. The top 200 UK law firm has a strong pipeline of opportunities, hardly surprising given that the pandamic induced economic downturn is likely to lead to a boom in dispute resolution work and employment related law suits.

I also note that RBG’s litigation finance arm expects to “execute four potentially significant commercial litigation financing transactions imminently” and has a growing pipeline of opportunities. Furthermore, the directors plan to sell a proportion of these investments as was the case in 2019. Selling down participation rights in contingent cases contributes to one-off revenues, and enables cash to be recycled into additional cases to diversifty the portfolio. Rosenblatt has an enviable track record of success in this area. Since taking on contingent work in 2011, the law firm has won 19 of the 22 cases that have concluded to date.

Convex Capital, the specialist sell-side corporate finance boutique acquired by RBG in September 2019, has a strong pipeline of deals (around 30 with each one potentially worth £1m in fees), albeit the Covid-19 pandemic has resulted in transaction deferrals and it’s uncertain how many deals will conclude in the second half. However, as I noted five weeks ago, there is silver lining. That’s because £6.6m of the deferred consideration on the acquisition price represents a contingent earn-out to be settled in shares (minimum issue price of 140p), but only if Convex exceeds a cash profit of £6m for the 12 months to mid-September 2020. In other words, RBG’s exisiting shareholders will avoid dilution if Convex fails to hit its target, but still retain 100 per cent ownership of the business. That’s not a bad outcome at all.

Trading on a price-to-book value of 1.3 times, historic price/earnings ratio of 8.5 and offering a trailing dividend yield of 4.6 per cent, the potential for Rosenblatt’s high earning legal eagles to continue to create value for shareholders is woefully undervalued. Buy.

Above is by Simon Thompson.

[scubadiverr] 14/7/2020 00:09

Only c. a 3rd are in public hands so will increase volility. It's also been ripped a number of times and MM's likey have taken advantage of that as well as profit takers. That's my take anyway